Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure

M. I. Vargas-Rojas, H. Solleiro-Villavicencio, A. Ramírez-Venegas, M. Velázquez-Uncal, R. Quintana, R. Sansores-Martínez (Mexico, Mexico)

Source: Annual Congress 2013 –COPD: new markers of diseases
Session: COPD: new markers of diseases
Session type: Thematic Poster Session
Number: 595
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. I. Vargas-Rojas, H. Solleiro-Villavicencio, A. Ramírez-Venegas, M. Velázquez-Uncal, R. Quintana, R. Sansores-Martínez (Mexico, Mexico). Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure. Eur Respir J 2013; 42: Suppl. 57, 595

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013


Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015

Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001

Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles
Source: Annual Congress 2009 - Indoor and outdoor air pollution
Year: 2009


Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014

Evasion of COPD in smokers: at what price?
Source: Eur Respir J 2012; 39: 1298-1303
Year: 2012



The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 608s
Year: 2004

Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007



Inflammation in COPD: a link to systemic comorbidities
Source: Eur Respir Rev 2007; 16: 91-97
Year: 2007



Tobacco use in relation to COPD and asthma
Source: Eur Respir J 2007; 29: 438-445
Year: 2007



Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014

Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms?
Source: Annual Congress 2005 - Lung structure: current concepts
Year: 2005


Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013